Report highlights global biopharma interest in China

Ninety percent of global biopharma companies are interested in expanding to Asia, with 86% citing China specifically, according to a report from L.E.K. Consulting and BIO unveiled on June 4. Of the 88 biopharma executives surveyed, 92% said interest

Read the full 396 word article

User Sign In